Hypertensive patients 80 years of age or older were randomized into treatment with Indapamide with or without Perindopril or placebo control to obtain a blood pressure goal of at least 150/80. Active treatment group showed a statistically significant reduction in several measured parameters, including: the rate of death from any cause, the rate of death from stroke, and the rate of developing heart failure. There was not a measured increase in the rate of significant adverse side effects with active treatment group versus placebo control.
The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.
Treatment of Hypertension in patients 80 years of age and older maintains its benefit in terms of both morbidity and mortality..
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.